Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/j.1752-8062.2011.00282.x http://scihub22266oqcxt.onion/10.1111/j.1752-8062.2011.00282.x C4567896!4567896!21707950     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Transl+Sci 2011 ; 4 (3): 188-98 Nephropedia Template TP {{tp|p=21707950|t=2011. A CTSA Agenda to Advance Methods for Comparative Effectiveness Research |pdf=|usr=}}{{21707950}} gab.com Text A CTSA Agenda to Advance Methods for Comparative Effectiveness Research JO: Clin Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=21707950 #FOAvip Clinical research needs to be more useful to patients, clinicians, and other decision makers. To meet this need, more research should focus on patient?centered outcomes, compare viable alternatives, and be responsive to individual patients? preferences, needs, pathobiology, settings, and values. These features, which make comparative effectiveness research (CER) fundamentally patient?centered, challenge researchers to adopt or develop methods that improve the timeliness, relevance, and practical application of clinical studies.In this paper, we describe 10 priority areas that address 3 critical needs for research on patient?centered outcomes (PCOR): (1) developing and testing trustworthy methods to identify and prioritize important questions for research; (2) improving the design, conduct, and analysis of clinical research studies; and (3) linking the process and outcomes of actual practice to priorities for research on patient?centered outcomes. We argue that the National Institutes of Health, through its clinical and translational research program, should accelerate the development and refinement of methods for CER by linking a program of methods research to the broader portfolio of large, prospective clinical and health system studies it supports. Insights generated by this work should be of enormous value to PCORI and to the broad range of organizations that will be funding and implementing CER. Clin Trans Sci 2011; Volume 4: 188?198 Twit Text FOAVip A CTSA Agenda to Advance Methods for Comparative Effectiveness Research ????Clin Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=21707950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=21707950 #FOAvip English Wikipedia <ref>{{Cite pmid|21707950}}</ref> A CTSA Agenda to Advance Methods for Comparative Effectiveness Research #MMPMID21707950 Helfand M; Tunis S; Whitlock EP; Pauker SG; Basu A; Chilingerian J; Harrell Jr. FE; Meltzer DO; Montori VM; Shepard DS; Kent DM Clin Transl Sci 2011[Jun]; 4 (3): 188-98 PMID21707950show ga Clinical research needs to be more useful to patients, clinicians, and other decision makers. To meet this need, more research should focus on patient?centered outcomes, compare viable alternatives, and be responsive to individual patients? preferences, needs, pathobiology, settings, and values. These features, which make comparative effectiveness research (CER) fundamentally patient?centered, challenge researchers to adopt or develop methods that improve the timeliness, relevance, and practical application of clinical studies.In this paper, we describe 10 priority areas that address 3 critical needs for research on patient?centered outcomes (PCOR): (1) developing and testing trustworthy methods to identify and prioritize important questions for research; (2) improving the design, conduct, and analysis of clinical research studies; and (3) linking the process and outcomes of actual practice to priorities for research on patient?centered outcomes. We argue that the National Institutes of Health, through its clinical and translational research program, should accelerate the development and refinement of methods for CER by linking a program of methods research to the broader portfolio of large, prospective clinical and health system studies it supports. Insights generated by this work should be of enormous value to PCORI and to the broad range of organizations that will be funding and implementing CER. Clin Trans Sci 2011; Volume 4: 188?198 äA CTSA Agenda to Advance Methods for Comparative Effectiveness Researc(epmc).pdf DeepDyve Pubget Overpricing